Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$41.3M
+4.4% from 2023
Prescriptions
2,032
$20,307.57 per claim
Patients
110
89 prescribers
Total spending, 2024
$41.3M
$375,136.28 per patient
Medicare prescription drug plans paid $41.3M for Fabrazyme in 2024, for 2,032 prescriptions and refills to 110 patients (up 4.4% from 2023). The average cost per claim was $20,307.57.
California had the highest Medicare cost for Fabrazyme in 2024: $4.6M for 220 claims, followed by New York ($4.5M).
Jaya B Ganesh, pediatric medicine in New York, NY, had the highest Medicare cost for Fabrazyme in 2024: 81 claims costing $1.9M.
Fabrazyme is made by Sanofi (SNY), listed in the Medicare spending data as Genzyme.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jaya B Ganesh New York, NY | Pediatric Medicine | 81 | Under 11 | $1.9M |
| Hua Wang San Bernardino, CA | Pediatric Medicine | 25 | Under 11 | $1.7M |
| Marie McDonald |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 82 | 1,813 | 99 | $37.3M |
| 2023 | 90 | 1,817 | 101 | $39.5M |
| 2024 | 89 | 2,032 | 110 | $41.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pediatric Medicine |
| 71 |
| Under 11 |
| $1.4M |
| Kaila Niehaus Cincinnati, OH | Nurse Practitioner | 74 | Under 11 | $1.3M |
| Pramod K Mistry New Haven, CT | Gastroenterology | 42 | Under 11 | $1.2M |
| Damara Ortiz Pittsburgh, PA | Pediatric Medicine | 26 | Under 11 | $1.0M |
| Gina M Lewis Milwaukee, WI | Nurse Practitioner | 58 | Under 11 | $990K |
| Ozlem Goker-Alpan Fairfax, VA | Pediatric Medicine | 52 | Under 11 | $976K |
| Virginia E Kimonis Orange, CA | Pediatric Medicine | 66 | Under 11 | $956K |
| Andrew Levine McAllen, TX | Nephrology | 48 | Under 11 | $830K |
| Ahmad M Tuffaha Kansas City, KS | Nephrology | 48 | Under 11 | $787K |
| Jasmine L Knoll Phoenix, AZ | Medical Genetics and Genomics | 38 | Under 11 | $748K |
| Staci M Kallish Philadelphia, PA | Pediatric Medicine | 26 | Under 11 | $748K |
| Hunter R Underhill Salt Lake City, UT | Pediatric Medicine | 24 | Under 11 | $733K |
| Marc H Stegman Memphis, TN | Nephrology | 24 | Under 11 | $730K |
| Joseph H Hersh Louisville, KY | Medical Genetics and Genomics | 17 | Under 11 | $725K |
| Darius J Adams Morristown, NJ | Family Practice | 28 | Under 11 | $723K |
| Claudia Zacharek Saginaw, MI | Nephrology | 28 | Under 11 | $711K |
| Amy K Mottl Sanford, NC | Nephrology | 28 | Under 11 | $701K |
| Maryam Banikazemi Valhalla, NY | Medical Genetics and Genomics | 48 | Under 11 | $658K |
| Chester B Whitley Minneapolis, MN | Pediatric Medicine | 58 | Under 11 | $626K |
| Stephanie J Offord Milwaukee, WI | Nurse Practitioner | 24 | Under 11 | $601K |
| Kimberly R McDonald Louisville, KY | Neurology | 12 | Under 11 | $593K |
| Anthony A Perszyk Ponte Vedra Beach, FL | Medical Genetics and Genomics | 13 | Under 11 | $581K |
| Imran Tahir Chicago, IL | Nephrology | 13 | Under 11 | $572K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genzyme SNY | 2,032 | $41.3M |